Bacterin International, Inc. Announces The Launch Of OsteoSTX, A Novel Biologic Product

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE) is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin’s proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.

Help employers find you! Check out all the jobs and post your resume.

Back to news